Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 1,924.06 ($23.67) and traded as high as GBX 2,064 ($25.40). Hikma Pharmaceuticals shares last traded at GBX 2,062 ($25.37), with a volume of 345,386 shares.
Hikma Pharmaceuticals Price Performance
The stock has a market capitalization of £4.58 billion, a price-to-earnings ratio of 3,172.32, a PEG ratio of 2.38 and a beta of 0.41. The company has a debt-to-equity ratio of 55.48, a quick ratio of 1.27 and a current ratio of 1.66. The company has a 50 day moving average of GBX 1,924.57 and a 200 day moving average of GBX 1,924.06.
Hikma Pharmaceuticals Company Profile
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Recommended Stories
- Five stocks we like better than Hikma Pharmaceuticals
- The 3 Best Retail Stocks to Shop for in August
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- How to Capture the Benefits of Dividend Increases
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
